Clinical Trials Directory

Trials / Sponsors / Vaxcyte, Inc.

Vaxcyte, Inc.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingSafety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination
Pneumococcal Vaccines
Phase 32026-02-09
Active Not RecruitingA Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in
Pneumococcal Vaccines
Phase 32026-01-12
Active Not RecruitingSafety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
Pneumococcal Vaccines
Phase 32025-12-01
Active Not RecruitingA Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
Pneumococcal Vaccines
Phase 22024-11-25
CompletedSafety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adult
Pneumococcal Vaccines
Phase 1 / Phase 22023-11-08
CompletedSafety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Inf
Pneumococcal Vaccines
Phase 22023-03-29
CompletedSafety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older
Pneumococcal Vaccines
Phase 22022-06-15
CompletedSafety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adult
Pneumococcal Vaccines
Phase 1 / Phase 22022-02-22